top of page



Why PsyBio Will be the Leader in the Psychedelic Drug Discovery Industry
Progress for Top
40 Individual
Molecules

Current Pipeline:
88 Individual
Molecules

Fully Capitalized:
Triple Subscribed Institutional
Round

IND and Clinical Trials: Pre-IND Submission in 2021 & Clinical Trials in 2022

Intellectual Property:
Blanket Submissions in Combinatorial Bacterial and Hybrid Synthesis

Psybio Media
bottom of page